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VopE, a Vibrio cholerae Type III
Effector, Attenuates the Activation of
CWI-MAPK Pathway in Yeast Model
System
Leela K. Bankapalli, Rahul C. Mishra and Saumya Raychaudhuri *
Molecular Biology and Microbial Physiology, Institute of Microbial Technology, Chandigarh, India
VopE, a mitochondrial targeting T3SS effector protein of Vibrio cholerae, perturbs
innate immunity by modulating mitochondrial dynamics. In the current study, ectopic
expression of VopE was found to be toxic in a yeast model system and toxicity was
further aggravated in the presence of various stressors. Interestingly, a VopE variant
lacking predicted mitochondrial targeting sequence (MTS) also exhibited partial lethality
in the yeast system. With the aid of yeast genetic tools and different stressors, we
have demonstrated that VopE and its derivative VopE1MTS modulate cell wall integrity
(CWI-MAPK) signaling pathway and have identified several critical residues contributing
to the lethality of VopE. Furthermore, co-expression of two effectors VopE1MTS and
VopX, interfering with the CWI-MAPK cellular pathway can partially suppress the VopX
mediated yeast growth inhibition. Taken together, these results suggest that VopE alters
signaling through the CWI-MAPK pathway, and demonstrates the usefulness of yeast
model system to gain additional insights on the functionality of VopE.
Keywords: Vibrio cholerae, T3SS effector, GAPs, suppression analysis, yeast mitochondria, stressors, MAPK
signaling pathway
INTRODUCTION
The effectiveness of a microbe as a pathogen is largely dependent on its ability to subvert the host
defensemechanism. Inmany bacterial pathogens, the type 3 secretion system (T3SS) and associated
effector proteins are utilized to hijack host immune surveillance, further allowing survival of the
bacteria in hostile host environments. Multiple lines of converging evidences clearly demonstrate
the evolution of unique functional domains and motifs in several T3SS effector proteins, that
empower diverse pathogens to usurp disparate host cellular processes (Dean, 2011; Salomon et al.,
2013).
A T3SS secretion system and 11 bona fide effector proteins with unique structural and functional
features have been reported in Vibrio cholerae strains belonging to diverse serogroups and role of
these effector proteins in pathogenesis have been studied in vitro and also in vivo using animal
and yeast model system (Dziejman et al., 2005; Tam et al., 2007; Tripathi et al., 2010; Alam et al.,
2011). One such effector protein VopE, a close homolog of the Yersinia T3SS effector protein
YopE, disrupts the integrity of tight junctions by modulating actin homeostasis, thus promoting
pathogenecity of V. cholerae strain AM-19226 (Tam et al., 2010; Shin et al., 2011). Furthermore,
it has been demonstrated that VopE by virtue of a typical mitochondrial targeting sequence
(MTS) at the N-terminus localizes to the mitochondria where it alters mitochondrial dynamics
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and modulates innate immune signaling by interfering with
Miro GTPases (Suzuki et al., 2014). Sequence analysis reveals
the existence of GTPase-activating protein (GAP) domain at the
C-terminus of VopE (Suzuki et al., 2014). Such GAP domain
is also reported in other T3SS effector proteins such as YopE
(Yersinia pestis), SptP (Salmonella typhimurium), and ExoS
(Pseudomonas aeruginosa) which are known to target the actin
cytoskeleton in mammalian cells (Busch and Aktories, 2000).
Though sequence based structural features predict that VopE
shares structural homology with YopE, but VopE does not target
actin cytoskeleton (Suzuki et al., 2014).
There is a growing appreciation of the utility of Saccharomyces
cerevisiae, the budding yeast as a non-mammalian model system
to identify and evaluate the functionality of diverse arrays of
virulence factors from numerous pathogenic bacteria (Valdivia,
2004; Siggers and Lesser, 2008; Curak et al., 2009; Popa et al.,
2016). Simple ectopic expression of virulence factors can lead
to a variety of discernable phenotypes in yeast that help to
build testable hypotheses regarding their function and roles in
pathogenesis. There are seminal evidences where the function of
numerous effector proteins (e.g., YopE, SipA, Tarp, VopX etc.)
was first evaluated in the yeast model and documented later in
mammalian systems (Von Pawel-Rammingen et al., 2000; Lesser
and Miller, 2001; Galkin et al., 2002; Kumar et al., 2006; Sisko
et al., 2006; Siggers and Lesser, 2008; Alam et al., 2011). There are
instances where expression of certain effector proteins gave rise
to different phenotypes in yeast system than mammalian system,
thereby entailing additional function associated with a particular
effector (Siggers and Lesser, 2008). For example expression of
Map (T3SS effector protein of Escherichia coli) results in the
formation of filopodia in mammalian cells but its expression
in yeast model promotes the formation of large unbudded cells
(Rodríguez-Escudero et al., 2005). Additionally, yeast has also
been used as a model to gain new insights on mammalian
proteins (Pereira et al., 2012).
The mitogen-activated protein kinase (MAPK) signaling
pathways have been studied in great detail in S. cerevisiae
(Hunter and Plowman, 1997; Gustin et al., 1998). The MAPK
signaling pathway has been shown to be targeted by several
T3SS effectors of diverse pathogenic bacteria. For example, HOG
MAPK pathway of S. cerevisiae is targeted by VopA (Vibrio
parahemolyticus), YopJ (Yersinia sp.), and HopX1 (Pseudomonas
syringae) (Yoon et al., 2003; Trosky et al., 2004; Salomon et al.,
2012). YopJ also targets the pheromone responseMAPK pathway
in the yeast model system (Yoon et al., 2003). The T3SS effector
protein of V. cholerae, VopX has been reported to interfere with
the functioning of the CWI-MAPK pathway (Alam et al., 2011;
Seward et al., 2015). In sum, yeast model system reveals that
MAPK signaling pathways are potential targets of T3SS effector
proteins.
In this study, another T3SS effector protein of V. cholerae,
VopE has been investigated using yeast as a model system.
The results obtained clearly revealed that level of toxicity
of VopE is dependent on yeast genetic background and
is exacerbated in the presence of various stressors. Though
mitochondrial localization of VopE is important for full toxicity,
deletion of mitochondrial target sequence (MTS) still retained
partial lethality. By employing different stressors coupled with
β-galactosidase assay, VopE and its variant (VopE1MTS) were
found to interfere with MAPK pathway primarily affecting the
functioning of cell wall integrity (CWI) pathway. Interestingly,
screening yeast deletion library related to CWI cellular pathway
identified hypersensitive strains. Furthermore, the present work
also identified several critical residues contributing to VopE
function and unveiled how co-expression of two effectors,
VopE1MTS and VopX, targeting CWI-MAPK cellular pathway
in an opposing manner can suppress the VopX mediated yeast
growth inhibition.
MATERIALS AND METHODS
Strains and Plasmids
The strains and plasmids used in this study are listed in
Table 1. E. coli strains Nova blue or DH5α were used for
general cloning. The E. coli strains were propagated at 37◦C
in Luria Broth (LB) with agitation or on LB agar plates.
When appropriate, the growth medium was supplemented with
ampicillin (100 µg/ml). S. cerevisiae strains were grown at
30◦C in YPD [1% (w/v) yeast extract, 2% (w/v) peptone,
2% (w/v) glucose] broth or agar (2%). Media ingredients
were purchased from Himedia and Difco. Identity of all
BY4741 deletion strains were verified by UP TAG (barcode)
confirmation.
The vopE gene was amplified from the genomic DNA
of V. cholerae strain SC110 using the gene specific primers
and used to generate recombinant plasmids (Table 1). The
conserved residues or regions of VopE were either deleted
or substituted with alanine or glycine using Stratagene one
step mutagenesis kit. The recombinant plasmid pESCLEU-VopE
was used as a template for all mutagenesis reactions. The
desired constructs were further transformed into S. cerevisiae
strains.
For localization studies, all VopE constructs were C-
terminally tagged with mCherry (from pmCherry-C1,
Clonetech) by an overlapping PCR as described earlier
(Tripathi et al., 2010). For mitochondrial visualization,
COX4-GFP fragment was constructed by fusing a fragment
encoding first 63 bases of COX4 to a gene encoding GFP
(from pGREG575) by overlapping PCR method. This
construct was further inserted into pRS413. This recombinant
plasmid pCOX4-GFP was transformed into BY4741 to
generate reporter strain BY4741-COX4-GFP. For Gem1
over expression, Gem1 gene was amplified from genomic DNA
of BY4741 with NotIF/PacIR primers, and further inserted
into pESCLEU-VopE to generate dual expression plasmid
pESCLEU-VopE-Gem1. For VopX expression, vopX gene
was amplified from the genomic DNA of V.cholerae strain
SC110 using the gene specific primers, and subsequently
inserted into NotI/PacI sites of pESCLEU or pESCLEU-VopE
to generate recombinant plasmids. For protein detection,
VopE constructs were tagged at C-terminus with 3XFLAG.
All recombinant plasmids constructed in this study (Table 1)
were confirmed by sequencing and maintained in E. coli
strains.
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TABLE 1 | Strains and plasmids used in this study.
Strains/plasmids Genotype/Description Source/References
E. coli
NovaBlue E. coli K-12, recA endA, lacIq, lacY Novagen
DH5α F– Φ80lacZ∆M15 ∆( lacZYA-argF) U169 recA1 endA1 hsdR17 (rK–,
mK+) phoA supE44 λ– thi-1 gyrA96 relA1
Microbial Type Culture Collection
and Gene Bank (MTCC)
V. cholerae
SC110 Non-O1/non-O139 strain of V. cholerae serogroup O34 Tripathi et al., 2010
S. cerevisiae strains
BY4741 MATa; his3∆ 1; leu2∆ 0; met15∆ 0; ura3∆ 0 Bankapalli et al., 2015
BY4741 1bck1 MATa; his3∆ 1; leu2∆ 0; met15∆ 0; ura3∆ 0; bck11::kanMX4 EUROSCARF
BY4741 1slt2 MATa; his3∆ 1; leu2∆ 0; met15∆ 0; ura31 0; slt21::kanMX4 EUROSCARF
BY4741 1ire1 MATa; his3∆ 1; leu2∆ 0; met15∆ 0; ura31 0; ire11::kanMX4 EUROSCARF
BY4741 1fus3 MATa; his3∆ 1; leu2∆ 0; met15∆ 0; ura3∆ 0; fus31::kanMX4 EUROSCARF
BY4741 1kss1 MATa; his3∆ 1; leu2∆ 0; met15∆ 0; ura3∆ 0; kss11::kanMX4 EUROSCARF
BY4741 1smk1 MATa; his3∆ 1; leu2∆ 0; met15∆ 0; ura3∆ 0; smk11::kanMX4 EUROSCARF
BY4741 1rlm1 MATa; his3∆ 1; leu2∆ 0; met15∆ 0; ura3∆ 0; rlm11::kanMX4 EUROSCARF
BY4741 1kdx1 MATa; his3∆ 1; leu2∆ 0; met15∆ 0; ura3∆ 0; kdx11::kanMX4 EUROSCARF
BY4741 1yca1 MATa; his3∆ 1; leu2∆ 0; met15∆ 0; ura3∆ 0; yca11::kanMX4 EUROSCARF
BY4741 1gem1 MATa; his3∆ 1; leu2∆ 0; met15∆ 0; ura3∆ 0; gem11::kanMX4 EUROSCARF
BY4741 1dnm1 MATa; his3∆ 1; leu2∆ 0; met15∆ 0; ura3∆ 0; dnm11::kanMX4 EUROSCARF
BY4741 1fzo1 MATa; his3∆ 1; leu2∆ 0; met15∆ 0; ura3∆ 0; fzo11::kanMX4 EUROSCARF
BY4741 1mtg1 MATa; his3∆ 1; leu2∆ 0; met15∆ 0; ura3∆ 0; mtg11::kanMX4 EUROSCARF
BY4741 1mtg2 MATa; his3∆ 1; leu2∆ 0; met15∆ 0; ura3∆ 0; mtg21::kanMX4 EUROSCARF
BY4741 1hog1 MATa; his3∆ 1; leu2∆ 0; met15∆ 0; ura3∆ 0; hog11::kanMX4 EUROSCARF
BY4741 1mkk1 MATa; his3∆ 1; leu2∆ 0; met15∆ 0; ura3∆ 0; mkk11::kanMX4 EUROSCARF
BY4741 1mkk2 MATa; his3∆ 1; leu2∆ 0; met15∆ 0; ura3∆ 0; mkk21::kanMX4 EUROSCARF
BY4741 1mgm1 MATa; his3∆ 1; leu2∆ 0; met15∆ 0; ura3∆ 0; mgm11::kanMX4 EUROSCARF
W303-1A MATa leu2-3,112 his3-11,15 ade2-1 ura3-1 trp1-1 can1-100 GAL
SUC2
Tripathi et al., 2010
Plasmids
pESCLEU 2µ,GAL1/GAL10,LEU2 Agilent
Technologies
pGML10 CEN6/ARSH4,GAL1,LEU2 RIKEN
pAMU10 CEN6/ARSH4,ADH1,URA3 RIKEN
pRS413 CEN6/ARSH4,TEF,HIS3 Gift from Dr. Deepak Sharma,
Institute of Microbial Technology
pESCLEU-VopE 615 bp vopE gene fragment amplified from genomic DNA of V. cholerae
SC110 with XhoI/NheI primers by PCR and cloned into similarly
digested pESCLEU under GAL1 promoter
This study
pESCLEU-VopER125A VopE harboring A in place of R at position 125 This study
pESCLEU-VopE124−80 VopE harboring deletion for 24–80 This study
pESCLEU-VopE11−80 VopE harboring deletion for 1–80 This study
pESCLEU-VopE1MTS VopE harboring deletion for 1–23 This study
pESCLEU-VopE1MTS R125A VopE harboring deletion for 1–23, A in place of R at position 125 This study
pESCLEU-VopE1119−121 VopE harboring deletion for 119–121 This study
pESCLEU-VopE1159−167 VopE harboring deletion for 159–167 This study
pESCLEU-VopEA120G VopE harboring G in place of A at 120 This study
pESCLEU-VopET129A VopE harboring A in place of T at 129 This study
pESCLEU-VopEQ161A VopE harboring A in place of Q at 161 This study
pESCLEU-VopEG163A VopE harboring A in place of G at 163 This study
pESCLEU-VopET164A VopE harboring A in place of T at 164 This study
pESCLEU-VopEF110A VopE harboring A in place of F at 110 This study
pESCLEU-VopEF162A VopE harboring A in place of F at 162 This study
pESCLEU-VopEV173A VopE harboring A in place of V at 173 This study
(Continued)
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TABLE 1 | Continued
Strains/plasmids Genotype/Description Source/Reference
pESCLEU-mCherry mCherry gene fragment was inserted into pESCLEU at XhoI, NheI sites
under GAL1 promoter
This study
pESCLEU-VopE-mCherry vopE-mCherry fragment was inserted into pESCLEU at XhoI, NheI sites
under GAL1 promoter
This study
pESCLEU-VopER125A-mCherry vopER125A-mCherry fragment was inserted into pESCLEU at XhoI, NheI
sites under GAL1 promoter
This study
pESCLEU-VopE1MTS-mCherry vopE∆MTS-mCherry fragment was inserted into pESCLEU at XhoI, NheI
sites under GAL1 promoter
This study
pESCLEU-Gem1 1.99 kb Gem1 gene fragment amplified from genomic DNA of BY4741
with NotI/PacI primers by PCR and cloned into similarly digested
pESCLEU under GAL10 promoter
This study
pESCLEU-VopE-Gem1 vopE (XhoI/NheI) and Gem1 (NotI/PacI) fragments were cloned in
pESCLEU under GAL1 and GAL10 promoters, respectively
This study
pESCLEU-VopX vopX obtained by NotI/PacI primers inserted into pESCLEU under
GAL10 promoter
This study
pESCLEU-VopE-VopX vopE (XhoI/NheI) and vopX (NotI/PacI) fragments were cloned in
pESCLEU under GAL1 and GAL10 promoters respectively
This study
pESCLEU-VopE1MTS-VopX vopE ∆MTS (XhoI/NheI) and vopX (NotI/PacI) fragments were cloned in
pESCLEU under GAL1 and GAL10 promoters, respectively
This study
pESCLEU-VopE1MTS R125A-VopX vopE1MTS R125A (XhoI/NheI) and vopX (NotI/PacI) fragments were
cloned in pESCLEU under GAL1 and GAL10 promoters, respectively
This study
pGML10-VopE 615 bp vopE gene fragment amplified from pESCLEU-VopE with
BamHI/EcorI primers by PCR and cloned into similarly digested
pGML10 under GAL1 promoter
This study
pAMU10-VopE 615 bp vopE gene fragment amplified from pESCLEU-VopE with
BamHI/EcorI primers by PCR and cloned into similarly digested
pAMU10 under ADH1 promoter
This study
pRS413-COX4-GFP Amplified COX4-GFP fragment cloned into XbaI, BamHI sites of pRS413
under TEF promoter
This study
pKT760 HOG 8xCRE-lacZ, TRP1 Gift from Dr. Guido Sessa, Tel
Aviv University, Israelp1434 CWI 2xRlm1-lacZ, URA3
pMCZ UPR, UPRE-lacZ, URA3
Pheromone MAPK pathway Reporter plasmid Pheromone, PFUS1-lacZ, URA3
Yeast Growth and Viability Assays
Yeast growth assays were performed as described earlier
(Tripathi et al., 2010; Bankapalli et al., 2015). Briefly, overnight
cultures of all recombinant strains in selective SCRaf medium
were diluted and grown again in same media at 30
◦
C until
exponential phase (OD600 ∼ 0.8–1.0). Effect of the expression of
VopE, its derivatives and VopX on the growth of S. cerevisiae
strains was examined by spotting equal number of cells onto
SC and SCGal plates lacking the corresponding auxotrophic
markers to maintain the plasmids. When necessary, liquid
growth induction was done for 6 h by adding galactose (2%) to
cultures before spotting. Growth was monitored after 60–70 h at
30◦C and photographed accordingly. Liquid growth assay was
done as described earlier (Bankapalli et al., 2015). For yeast
viability plating assay (cfu), recombinant stains carrying VopE
or its variants were grown overnight in selective SCRaf media.
Cultures were again diluted to OD600 0.1 in fresh media and
incubated up to OD600 ∼1.0 where cultures were resuspended in
selective SCGal media. At different times after induction, aliquots
were removed, and serial dilutions were plated on selective SC
solid media. Plates were incubated for 2–3 days at 30◦C before
viable colonies were counted (Salomon et al., 2011).
Yeast β-Galactosidase Assay
S. cerevisiae strain BY4741 harboring pESCLEU-VopE (BY4741-
VopE) was transformed with various lacZ reporter plasmids
as listed in Table 1 (2XRlm1-lacZ, PFUS1-lacZ, and UPRE-
lacZ). The HOG pathway related lacZ reporter plasmid (HOG
8XCRE-lacZ) was transformed into W303-1A strain harboring
pESCLEU-VopE (W303-VopE). All the plasmids were obtained
as gift from Dr. Guido Sessa, Tel Aviv University, Tel Aviv, Israel
(Salomon et al., 2012). For β-galactosidase assay, we followed
the published protocol (Salomon et al., 2012). Briefly, overnight
cultures of recombinant strains were diluted in selective medium
containing raffinose (2%) and grown to OD600 0.6–0.9. Galactose
(2%) was added and incubated for 6 h. Equal amount of cultures
were then distributed into two tubes. In one set, stressors were
added and kept for stipulated period as given. To activate the
HOG pathway, 0.5 M NaCl for 1 h; to activate the CWI pathway,
3 mM caffeine for 4 h; to stimulate the UPR, 2 mM DTT for
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4 h; to induce the pheromone signaling pathway, 5 µM α-
factor for 2 h. Cells were finally harvested and subjected to rapid
permeabilization procedure as described earlier (Kippert, 1995).
Activity is reported as percentage of Miller units.
Preparation of Yeast Extracts and
Immunoblot Analysis
The immunoblot analysis was carried out based on previous work
(Tripathi et al., 2013; Bankapalli et al., 2015). All the recombinant
yeast strains carrying wild type VopE and its congeners were
grown in selective SCRaf medium at 30◦C until mid-log phase.
The cultures were then diluted in selective induction media
(SCGal). After 6 h of induction, cultures were pelleted and whole
cell protein extracts were prepared by adopting a published
protocol (Zhang et al., 2011). Equal amount of protein samples
were fractionated by SDS-polyacrylamide gel electrophoresis
using 12% polyacrylamide gel and transferred to Immobilon–
P Transfer Membrane (Millipore). Membrane was probed with
either Monoclonal anti-FLAG M2-Peroxidase (HRP) Clone M2
(Sigma) antibody or anti-Porin (yeastmitochondria)Monoclonal
Antibody (Invitrogen, Mitosciences). The primary antibody was
detected using a horseradish peroxidase conjugated anti-mouse
antibody (Millipore) and blot was developed with LuminataTM
Forte Western HRP substrate.
Yeast Confocal Microscopy and
Subcellular Fractionation
To investigate the localization of VopE and its mutagenized
congeners, recombinant yeast strains harboring these constructs
(Table 1) were harvested after galactose induction. Samples were
observed by Confocal Laser Scanning Microscope (Nikon A1R).
For isolation of mitochondria, yeast cells containing vector
(pESCLEU), or VopE were grown in selective SC media and
grown again in 500 ml of fresh media till OD600 was 1.5.
Subsequently, cells were harvested and expression of VopE was
induced by re-suspending the pellet in 500ml of selective SCGal
media for 6 h. Purification of yeast mitochondria was performed
according to standard procedure (Gregg et al., 2009).
RESULTS
Ectopic Expression of VopE in S. cerevisiae
Affects Cell Growth
Several V. cholerae strains belonging to non-O1, non-O139
serogroups (laboratory collection) were examined for the
presence of the vopE gene. The gene fragment was PCR amplified
and cloned under the control of GAL1 promoter in the high
copy number vector pESCLEU to generate recombinant plasmid
pESCLEU-VopE. Next, VopE (A33_1662) was ectopically
expressed in a S. cerevisiae strain W303-1A. Under inducing
condition, spotting on solid agar media exhibited no growth
inhibition, where as in liquid media strong growth inhibition
was observed (Figure 1A, left and right panels). As reported,
certain effectors exhibit an altered toxicity in solid and liquid
growth assay conditions in yeast model system (Kramer et al.,
2007; Siggers and Lesser, 2008; Antic et al., 2014). Interestingly,
it has been documented that effector driven growth inhibition is
dependent on different yeast genetic backgrounds (Rodríguez-
Pachón et al., 2002; Bénit et al., 2010; Salomon et al., 2011). To
ascertain the function of VopE in another genetic background,
we transformed the pESCLEU-VopE recombinant construct into
strain BY4741. An increase in lethality of VopE in BY4741 genetic
background over that in W303-1A was observed (Figure 1B left
and right panels).
Activity of bacterial effectors carrying GAP domain largely
depend on arginine residue, referred as the arginine finger. VopE
is a member of bacterial GAP effector family and also carries a
conserved arginine along with additional GAP domain features.
To ascertain the contribution of arginine at position 125 in VopE
mediated toxicity in yeast system, we exchanged arginine with
alanine and evaluated the lethality of recombinant VopER125A
variant. The data clearly demonstrated significant loss in lethality
of VopER125A variant, thereby underscoring the importance of
arginine residue in the functionality of VopE in yeast system
(Figure 1B left panel). To investigate in vivo protein stability,
wild type and VopER125A were C-terminally tagged with FLAG
epitope and western blot analysis using anti-FLAG antibody was
carried out (Zhang et al., 2011; Tripathi et al., 2013). The results
indicated that VopE and VopER125A were found to be stable
(Figure 2C). The viability of yeast carrying VopE or VopER125A
was also determined by CFU assay at different time periods up
to 24 h. A gradual decrease in number of viable cells suggesting
that growth inhibition caused by VopE is due to loss of viability
(Figure 1D).
Although, bacteria encode different T3SS effector proteins,
quantity of each effector translocated into host varies in amount
during infection. Earlier studies have clearly demonstrated that
low level expression of effector proteins increases the specificity
while high level expression promotes sensitivity of inhibition
in yeast model system (Slagowski et al., 2008). In some cases,
it is also surmised that high level expression may result in
non-specific toxic effects (Salomon et al., 2012). Therefore,
we wanted to ascertain whether low level expression of VopE
maintains similar toxicity as presented in the preceding section,
the gene encoding wild type VopE was cloned in pGML10,
a low copy number vector (Table 1). Unlike yeast harboring
pESCLEU-VopE construct, recombinant yeast cells transformed
with pGML10-VopE showmild growth defect, further indicating
that VopE toxicity depends on the level of expression (Figures 1C
and 1B right panel). As evidenced, several effector proteins
exhibit toxicity only when expressed at high level (Slagowski
et al., 2008). During analyzing the function of various Legionella
pneumophila effectors in yeast system, it appears that toxicity
of some effectors manifests only at high level while others are
independent of the level of expression (Havey and Roy, 2015).
VopE Variant Lacking Mitochondrial Target
Sequence (VopE1MTS) Retains Partial
Lethality
VopE contains predicted MTS spanning N-terminal 23 amino
acids and removal of this stretch has been reported to affect VopE
localization to mitochondria (Suzuki et al., 2014). To investigate
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FIGURE 1 | Effect of VopE on Yeast growth. (A) W303-1A transformants carrying VopE or VopER125A under control of GAL1 promoter were subjected to spotting
on selective solid media containing glucose (repressor) or galactose (inducer). Liquid growth assay shown on right panel. Yeast harboring pESCLEU (high copy vector)
treated as control. (B) Similar experiment was performed in BY4741 genetic background with pESCLEU cloning vector. (C) BY4741 transformants harboring pGML10
(low copy vector) or VopE were subjected to spotting under selective solid media containing glucose or galactose conditions. Liquid growth assay shown in (B) right
panel. (D) For yeast growth viability analysis, BY4741 strains carrying VopE constructs were sampled at each time point and 10-fold serial dilutions were plated on
glucose plate to count viable cells. Error bar indicates standard deviation from mean. Each experiment repeated three times with similar results.
the cellular fate of VopE variant lacking MTS (henceforth
known as VopE1MTS), growth of recombinant strain BY4741-
VopE1MTS carries a VopE1MTS in high copy number vector was
examined under inducing condition. Solid agar spotting data
indicate that (VopE1MTS) retains some ability to intoxicate yeast
cells albeit less than wild type protein VopE (Figure 2B, left
panel). The spotting data were further corroborated by liquid
growth assay where a similar trend of growth inhibition was
noticed (Figure 2B, right panel). To ensure in vivo stability of
VopE1MTS, western blot was performed by using anti-FLAG
antibody (Figure 2C). In growth viability assay, number of
growing cells increased for first 12 h, and then maintained as
constant number of viable cells (Figure 1D).
Identification of Additional Conserved
Structural Unit Contributing VopE Activity
Structural and sequence analysis reveal certain unique features
essential for optimal performance of different bacterial GTPase-
activating proteins (GAPs) (Litvak and Selinger, 2003). For
example, there are several conserved residues and two bulge
regions (I & II) in bacterial GAPs whose mutual interactions
maintain the precise orientation of the critical arginine and
catalytic efficiency of the GAPs. The catalytic arginine residue
within the bulge I interacts with the nucleotide phosphate
and with the conserved residues of bulge II (Stebbins and
Galan, 2000; Wurtele et al., 2001; Litvak and Selinger, 2003).
Sequence alignment of VopEwith other bacterial GAPs identified
bulge II region (Figure 3A). To examine the importance of
this region in VopE function, the bulge II region (amino acids
159–167) was deleted and the activity of VopE1159−167 variant
was examined in yeast strain BY4741. A loss of lethality was
observed in the yeast strain carrying the VopE1159−167 variant
(Figure 3B) further corroborating the importance of bulge II
region in VopE function. Next, we turned our attention on other
amino acids (V119, A120, N121, T129, Q161, G163, T164) predicted
to involve in network of multiple interactions (Figure 3A). A
series of VopE variants carrying alanine substitutions (T129A,
Q161A, G163A, and T164A), glycine substitution (A120G) or
VAN deletion (1119–121) were constructed and their effect
was examined in yeast. Significant loss in lethality of VopE
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FIGURE 2 | VopE1MTS induced yeast growth inhibition. (A) Schematic representation of VopE domain or motif (B) BY4741 strains carrying pESCLEU or
VopE1MTS were spotted on solid selection media containing glucose or galactose (left panel). Same cultures also inoculated in liquid selection media containing
galactose (right panel). (C) In vivo stability of VopE-3XFLAG and its derivatives confirmed by immunoblot using anti-FLAG antibody.
FIGURE 3 | Identification of residues and regions of VopE contributed in yeast toxicity. (A) Alignment of VopE along with other bacterial GTPase-activating
protein sequences as carried out by Clustal Omega. Conserved and semi-conserved amino acid positions are highlighted with red and blue respectively. Predicted
amino acids (*) involved in multiple interactions with unknown yeast target protein(s) or selected hydrophobic amino acids (N) are substituted with alanine or glycine.
The GenBank identifiers and species name are as follows: YopE [31795304|Yersinia pestis]; SptP[16421425|Salmonella typhimurium str. LT2]; VopE
[254285224|Vibrio cholerae AM19226]; ExoS [450297| Pseudomonas aeruginosa]. (B) BY4741 cultures carrying a vector, either pESCLEU or VopE variants were
10-folded serial diluted and subjected to spotting on selective solid media containing glucose or galactose. (C) Expression of VopE-3XFLAG variants verified by
western blot using anti-FLAG antibody.
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alanine (T129A, Q161A, G163A, T164A) and deleted (1VAN)
variants (Figure 3B), thereby indicating the significance of these
interacting residues in maintaining VopE function in addition
to arginine125 residue. It should be noted that toxicity of VopE
variant harboring glycine at position 120 (VopEA120G) remains
unperturbed.
In addition to the residues posited in bulge I and II regions,
there are residues participating in the formation of hydrophobic
core in the GAP domain of SptP (Stebbins and Galan, 2000).
Based on Clustal Omega alignment of VopE with SptP, ExoS,
and YopE, three amino acids such as F110, F162, and V173 were
selected that might contribute to the formation of hydrophobic
core of VopE (Figure 3A). Subsequent replacement of these
amino acids with alanine resulted in loss of functionality of VopE
(Figure 3B). Interestingly, non-conserved region might also
contribute to the function of any given protein (Sampath et al.,
2003). Indeed, when a non-conserved region spanning 24–80
amino acids (Figure 2A) was deleted, the resultant VopE1 24–80
variant was found to be non-lethal in yeast model system
(Figure 3B). Collectively, our effort led to the identification of
several GAP domain associated residues and non-conserved
region contributing to the functionality of VopE. To examine
in vivo stability, western blot analysis of recombinant yeast
strains harboring wild type and different VopE variants was
carried out by using anti-FLAG antibody. We found that all
the VopE derivatives were stable under in vivo condition except
VopE124–80 and VopE1 1–80 (Figure 3C).
Mitochondrial Localization of VopE in
S. cerevisiae
To examine mitochondrial localization of VopE in yeast model, a
yeast reporter strain BY4741-COX4-GFP was first constructed by
transforming pCOX4-GFP in S. cerevisiae BY4741. COX4-GFP
fusion protein (targeted to mitochondrial matrix) has been used
to visualize mitochondrial morphology in yeast (Otsuga et al.,
1998). Next, pVopE-mCherry was transformed into BY4741-
COX4-GFP to generate BY4741-COX4-GFP-VopE-mCherry. In
addition, VopE variants fused with mCherry (Table 1) were also
transformed into BY4741-COX4-GFP. Upon induction, VopE-
mCherry conferred growth inhibition in BY4741-COX4-GFP-
VopE-mCherry (Figure S1), thus indicating that the fusion
of mCherry at the C-terminus of VopE did not alter its
activity. To visualize localization of mCherry tagged variants, the
recombinant strains were harvested at 6 h following the addition
of galactose and visualized by confocal microscopy. Similar to
previous reports using mammalian cell lines, in yeast system
also VopE and VopER125A localize to mitochondria whereas
VopE1MTS was detected in the cytosol (Figure 4A). Localization
of VopE in mitochondria was further confirmed by sub cellular
fractionation where presence of VopE-3XFLAG signal in yeast
mitochondrial fraction was detected by immunoblot with anti-
FLAG antibody (Figure 4B).
Certain P. syringae pv. tomato DC3000 effectors (HopAA1-
1, HopAM1, HopAD1 etc.) when expressed in yeast have been
shown to impair respiration and their toxicity enhanced on
ethanol glycerol (EG) selective media (Munkvold et al., 2008). As
VopE targets to mitochondria, it was therefore conceivable that
VopE may alter respiration in yeast and show enhance killing
of yeast cells on glycerol. But spotting of recombinant yeast
strain harboring VopE cloned under constitutive or inducible
promoters did not show any enhanced killing of yeast cells
on selective media containing glycerol (2%; Figure 4C), thus
indicating VopE does not impair yeast respiration.
VopE Maintains Lethality in Yeast
Mitochondrial GTPase Deletion Strains
Inhibition of mitochondrial clustering by VopE is mediated
through the inactivation of Miro GTPases (Suzuki et al., 2014).
The mammalian miro Rho GTPase ortholog in the budding
yeast is Gem1p (Frederick et al., 2004). Like other miro proteins,
Gem1p also contains two GTPase domains, a pair of calcium
binding EF-hand motifs and C-terminal transmembrane (TM)
domain. Both GTPase domains and EF-hand motifs are essential
for Gem1p to maintain mitochondrial dynamics (Frederick et al.,
2004). To examine whether the VopE dependent lethality in
yeast system was also mediated by the Gem1p (yeast Miro
GTPase), VopE was transformed into the yeast strain lacking
Gem1p, BY47411gem1 (Table 1) and growth was assayed after
VopE expression. In addition, Gem1 was also over expressed in
wild type yeast harboring VopE. Unexpectedly, VopE expression
caused lethality in the gem1 deleted yeast strain and gem1 over
expressed strain (Figures 5A,B). Conversely, Gem1, the yeast
Miro GTPase is not targeted by VopE.
A battery of cellular components including several GTPases
namely mitochondrial Rho GTPases (Miro I and Miro
II), Fzo/mitofunsins (Mfn1 and Mfn2), Dnm1/Drp1/Dlp1,
Mgm1/Opa1/Msp1 contributing to mitochondrial dynamics
have been identified in yeast, flies, worms, and mammals (Shaw
and Nunnari, 2002; Frederick and Shaw, 2007). VopE expression
in a number of mitochondrial GTPase yeast deletion strains
(1dnm1, 1fzo1, 1mgm1, 1mtg1, 1mtg2) produced lethality
similar to that produced by VopE expression in the wild type
yeast strain (Figure 5A).
VopE Mediated Yeast Growth Inhibition
Was Exacerbated in the Presence of
Stressors: The Signaling Pathway
Many translocated bacterial effector proteins do not exhibit
lethality in yeast model system either due to non-conservation
of targets between yeast andmammalian system or because target
(s) is conserved but it is dispensable and not rate limiting for yeast
growth under normal conditions (Slagowski et al., 2008; Salomon
et al., 2011). In latter cases, certain compounds, or environmental
conditions known as “stressors” have been shown to increase the
sensitivity of yeast strains toward different effectors and aid in
the identification of effector mediated growth-retardation traits
(Siggers and Lesser, 2008). The commonly employed stressors are
(i) caffeine, a purine analog exerts pleiotropic effects in yeast and
activates the CWI MAP kinase pathway. The molecule is highly
toxic to the mutants of CWI pathway and Tor pathway (Parsons
et al., 2004; Kuranda et al., 2006); (ii) Sorbitol, an osmotic stressor
activates HOG (high osmolarity glycerol) MAP kinase pathway
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FIGURE 4 | VopE targeted to yeast mitochondria and does not impair respiration. (A) Plasmids encoding mCherry or VopE-mCherry variants were introduced
into yeast reporter strain BY4741-COX4-GFP. Mid-log phase cells were induced for 6 h by the addition of galactose. Mitochondria were visualized by COX4-GFP
(targeting to mitochondrial matrix). Cells were examined by confocal laser scanning microscopy to monitor the localization patterns of VopE-mCherry constructs.
Scale bar equals to 5 µm. (B) Detection of VopE-3XFLAG in mitochondrial fraction and whole cell lysate of 6 h galactose induced cultures with anti-FLAG antibody.
Mitochondrial fraction was confirmed with anti-porin antibody. (C) BY4741 transformants expressing VopE either constitutive (pAMU10, low copy vector, top panel) or
inducible (pESCLEU, high copy vector, bottom panel) were subjected to spotting on selective solid media containing glucose or 2% glycerol. For liquid growth
induction, liquid cultures were pretreated with galactose for 6 h before spotting.
and toxic to mutants of the HOG MAPK pathway (Gustin et al.,
1998; Hohmann, 2002); (iii) NaCl, an osmotic and ionic stressor
that exhibits high level toxicity to the mutants of HOG MAPK
pathway and ion homeostasis (Gustin et al., 1998; Hohmann,
2002; Auesukaree et al., 2009); (iv) tunicamycin, an inhibitor of
protein glycosylation shows extreme toxicity to the mutants of
unfolded protein response (UPR) pathway and mutants with cell
wall defects (Parsons et al., 2004); (v) DTT, a reducing agent, is
also known to induce ER stress (Papa et al., 2003; Bosis et al.,
2011); (vi) 37◦C heat stress, causes pleiotropic effects in yeast
(Auesukaree et al., 2009). It has also been demonstrated that
stressors also suppress the toxic activity of certain effectors. For
example, lethality of Coxiella burnetii effector CBU0388-CetCb2
has been shown to be repressed by caffeine (Lifshitz et al., 2014).
Since VopE showed no toxicity in S.cerevisiae strain W303-
1A as compared to BY4741 in spotting assay (Figures 1A,B),
the effect of various stressors on both S. cerevisiae strains
W303-1A and BY4741 harboring VopE was next examined.
For this purpose, the yeast strains were grown in the presence
of some established stressors like caffeine (3 mM), NaCl
(0.5 M), sorbitol (1 M), tunicamycin (0.3 µg/ml), and 37◦C.
Interestingly, VopE mediated lethality was observed in W303-
1A in the presence of the stressors (caffeine, NaCl, sorbitol,
and tunicamycin; Figure 6A). To further examine the cellular
targets of VopE lacking MTS variant (VopE1MTS), BY4741-
VopE1MTS recombinant strain was grown in the presence
of various stressors. We observed an increase in lethality of
VopE1MTS only in the presence of caffeine and tunicamycin
(Figure 6B). Since yeast growth in the presence of caffeine and
tunicamycin mediated stress condition require functional CWI
and UPR signaling pathways respectively (Parsons et al., 2004;
Kuranda et al., 2006), these results suggested that VopE and its
mutant form (VopE1MTS) strongly perturbed the activation of
CWI and UPR pathways. VopE also caused yeast growth failure
in osmotic conditions reflecting attenuation of high osmolarity
glycerol MAPK pathway. It may be noted that YopE, the Yersinia
homolog of VopE, also targets CWI pathway (Kramer et al.,
2007).
There are six MAPK cascades have been characterized in yeast
mediating response to different stimuli namely (i) pheromone
responsive pathway; (ii) filamentous growth pathway; (iii) high-
osmolarity glycerol pathway; (iv) STE vegetative pathway; (v)
nutrient starvation pathway; (vi) CWI pathway (Chen and
Thorner, 2007; Arias et al., 2011). In order to identify the specific
MAP kinase pathways which are majorly attenuated by VopE
and its truncated form (VopE1MTS), we performed lacZ-reporter
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FIGURE 5 | Deletion or Over expression of Gem1 does not rescue yeast growth inhibition. 10-fold serial dilutions of (A) indicated BY4741 deletion strains
containing eitheir pESCLEU or VopE (B) BY4741 transformants carrying either Gem1 alone or Gem1 and VopE, were subjected to spotting on selective solid media
with glucose or galactose.
assay with recombinant yeast strains harboring VopE and
VopE1MTS along with lacZ-reporter plasmids of various MAPK
signaling pathways (CWI, HOG, Pheromone) and ER stress
pathways (UPR). The results clearly showed that VopE inhibited
the activation of (i) pheromone signaling pathway (32%
inhibition); (ii) CWI pathway (73% inhibition); (iii) unfolded
protein response pathway (UPR; 70% inhibition). Interestingly,
VopE1MTS also significantly suppressed the activation of UPR
and CWI pathways (Figures 7A–C).
Targeting multiple MAPK pathways has been reported for
other effector proteins e.g., YopJ, HopX1 (Yoon et al., 2003;
Salomon et al., 2012). It may be noted that no inhibition
of lacZ reporter activity corresponding to HOG pathway was
observed (Figure 7D), but toxicity of VopE was observed in the
presence of NaCl and sorbitol (Figure 6A). Such discrepancy
has also been reported earlier, caffeine increases the toxicity
of XopE2, a T3SS effector of Xanthomonas campestris, but
no inhibition of lacZ reporter activity corresponding to CWI
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FIGURE 6 | Enhanced yeast toxicity under various stress conditions caused by VopE and VopE1MTS. Yeast growth inhibition phenotypes of (A) W303-1A
transformants carrying either VopE or VopER125A (B) BY4741 transformants carrying VopE or its derivatives were examined by spotting on solid selection media
containing galactose (inducing) plate without or with stressors. pESCLEU used as cloning vector. Stressors used in this experiment were as follows: Caffeine (3mM),
Tunicamycin (0.3 µg/ml), NaCl (0.5 M), Sorbitol (1 M), 37◦C. Corresponding stressor sensitized BY4741 deletion strains (1bck1, 1slt2, 1hog1, 1ire1) were also
spotted. Each experiment was repeated three times with similar results.
pathway in the presence of caffeine was observed (Bosis et al.,
2011).
VopE1MTS Showed Enhanced Toxicity in
Yeast Deletion Mutants of CWI Pathway
To test whether yeast MAPK pathway components modulate
the toxicity, we transformed VopE and VopE1MTS in yeast
strains deleted for MAPK components of different signaling
pathways namely CWI (1slt2), High osmolarity glycerol
(1hog1), Pheromone (1kss1), and sporulation (1smk1), and
examined their growth under galactose inducing conditions.
Of these, slt2 deletion strain expressing VopE1MTS showed
increased yeast growth inhibition than wild type (Figure 8A,
Figure S2).
The CWI pathway maintains cell wall integrity and gets
activated in the presence of diverse arrays of external stimuli
such as heat stress, mating pheromones, oxidative stress, pH
stress, cell wall mutations, cell wall stressors, and endoplasmic
reticulum stress all of which are known to cause cell wall stress
(Levin, 2005; Arias et al., 2011). We further examined the effect
of VopE and its truncated version on various yeast deletion
mutants of CWI pathway. Accordingly, VopE and VopE1MTS
were transformed into yeast deletion mutants (1bck1, 1mkk1,
1mkk2, 1rlm1, 1kdx1) and the recombinant yeast strains were
examined by spotting on solid agar plate. Unlike VopE, 1bck1
and1slt2mutants expressing VopE1MTS exhibit increased yeast
growth inhibition as compared to wild type strain (Figure 8A,
Figure S2). An increased toxicity in absence of bck1 and slt2
further indicates that VopE and VopE1MTS may activate a
cellular response opposing the function of Bck1p and Slt2p.
Such cases of hypersensitivity have been recorded with other
effectors (e.g., OspF, XopE2, CBU1676, and CBU0885) as well
(Kramer et al., 2007; Bosis et al., 2011; Lifshitz et al., 2014).
It should be noted that lethality of VopE and VopE1MTS was
observed to be enhanced by tunicamycin, an UPR pathway
activator. If VopE targets UPR pathway, then it should remain
non-lethal in yeast deletion mutant of UPR pathway (1ire1).
Instead, we observed maintenance of toxicity which further
emphasizes that VopE does not target UPR pathway (Figure S3).
It has been pointed out by Sessa and colleagues that tunicamycin
is highly toxic to mutants with cell wall defects (Salomon
et al., 2012). It is therefore possible toxicity of effectors
targeting CWI such as VopE is exacerbated in the presence of
tunicamycin.
Next, we wanted to investigate whether VopE mediated
growth inhibition was due to initiation of apoptosis. Thus,
we transformed VopE in yeast mutant 1yca1, carrying a
deletion in the metacaspase gene, YCA1 and subsequently
examined the viability of recombinant 1yca1 strain by solid
agar spotting assay. If VopE targets YCA1, 1yca1 strain should
remain viable in the presence of VopE. But we observed
VopE maintained its lethality in YCA1 deleted strain which
is comparable to wild type strain background (Figure 8B).
These observations further reinforce that VopE and VopE1MTS
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FIGURE 7 | Effect of VopE and VopE1MTS on yeast MAPK pathways and ER stress response. Under inducing conditions, (A) BY4741 yeast strains harboring
2X-Rlm1 regulated lacZ reporter plasmid and VopE or its derivatives were treated with 3 mM caffeine for 4 h. VopE and VopE1MTS significantly affect the activation of
CWI-MAPK pathway. (B) Unfolded protein response was examined by incubating BY4741 transformants carrying UPRE regulated lacZ reporter plasmid and VopE or
its derivatives in presence of 2 mM DTT for 4 h. VopE or VopE1MTS greatly hampered activation of UPR response. (C) Activation of PFUS1-regulated lacZ reporter
was also monitored for BY4741 transformants carrying reporter plasmid and VopE or its derivatives in response to 5 µM α-factor for 2 h. Reduced activation of
pheromone MAPK pathway has been observed in the presence of VopE. (D) For HOG-MAPK pathway, W303-1A strains containing 8 × CRE-regulated lacZ reporter
and VopE or its derivatives were incubated in the presence of NaCl (0.5 M) for 1 h. Activation of reporter activity was not effected. Error bar depict the standard
deviation from mean of three independent clones. All experiments were repeated three times with similar results. For VopE and VopE1MTS, an asterisk(s) indicates a
statistically significant difference in mean values as compared to pESCLEU. For VopER125A, an asterisk(s) indicates a statistically significant difference in mean values
as compared to VopE (*p < 0.05; **p < 0.001; ns-not significant; unpaired, two tailed student’s t-test).
interact with the components of cell wall maintenance related
pathways.
Co-Expression of VopE1MTS Partially
Ameliorates the Lethal Effect of VopX in
Yeast
Co-expression of two effectors in yeast model has proven
valuable in identification of suppressor function of certain
effectors over other. Previously, it has been shown that L.
pneumophila effectors, SidD, and SidJ were able to counteract
the activity of SidM and SdeA respectively (Tan and Luo,
2011; Havey and Roy, 2015). We investigated the outcome of
co-expression of VopE1MTS with another V. cholerae effector
VopX targeting similar cellular pathway, the CWI pathway
in yeast (Alam et al., 2011; Seward et al., 2015). The dual
expression constructs (Table 1) were transformed to S. cerevisiae
strain BY4741. The recombinant yeast strains were subjected
to solid agar spotting under galactose inducing condition. We
observed a partial suppression of VopX mediated toxicity in
dual expression condition by VopE1MTS only (Figure 9). To
further confirm the specificity, we co-expressed the functionally
inert variant of VopE1MTS harboring the substitution of catalytic
arginine at position 125 with alanine (VopE1MTS R125A) along
with VopX. We observed that VopE1MTS R125A did not inhibit
VopX mediated toxicity further supporting the hypothesis that
VopE1MTS mediates suppression of VopX toxicity (Figure 9).
To summarize, the present work unfolds many additional
features on functional aspects of VopE by exploiting yeast
model system. These are as follows: (i) identification of
several critical residues in GAP domain and N-terminal
region of VopE conferring lethality in yeast system; (ii)
VopE variant lacking mitochondrial localization signal
possesses partial lethality; (iii) screening of yeast deletion
library against VopE and its derivative VopE1MTS results in the
identification of hypersensitive strains; (iv) VopE and VopE1MTS
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FIGURE 8 | Examination of VopE effect on CWI defective and metacaspase mutants. (A) BY47411bck1 and BY47411slt2 yeast deletion mutant strains
showed increased yeast growth inhibition phenotype toward VopE1MTS. (B) Over expression of VopE maintains toxicity in BY47411yca1 strain. All transformants
were examined under solid selection media containing glucose or galactose. pESCLEU used as cloning vector.
modulates CWI-MAPK pathway in yeast; (v) co-expression of
VopE1MTS and VopX causes functional perturbation of the
latter.
DISCUSSION
In this study the budding yeast has been exploited as
a model organism for functional exploration of VopE, a
T3SS effector protein of V. cholerae. Previously, yeast has
been used as a model organism to study the activity of
several other V. cholerae T3SS effector proteins (Tripathi
et al., 2010, 2013; Bankapalli et al., 2015; Seward et al.,
2015).
It is now evident that one important host organelle
targeted by several pathogens is the mitochondria (Jiang et al.,
2012). Usually, proteins targeted to the mitochondria harbor
specific signal sequence known as mitochondrial targeting signal
(MTS) at the N-termini contributing to their import into
mitochondria. Site-directed mutagenesis of MTS reveals the
identification of critical residue (s) involved in the mitochondrial
transportation of certain effectors (e.g., Map, EspF) (Nagai et al.,
2005; Papatheodorou et al., 2006). In case of some proteins,
PorB (Neisseria gonorrhoeae), and VacA (Helicobacter pylori),
removal of N and C-termini did not affect their mitochondrial
localization, indicating that signals are not restricted at the
termini only (Kozjak-Pavlovic et al., 2009; Foo et al., 2010;
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FIGURE 9 | Expression of VopE1MTS suppresses yeast growth inhibition of VopX. (A) BY4741 transformants carrying VopX and VopE1MTS, VopX and
VopE1MTS R125A, or VopX and VopE were spotted on glucose and galactose plates. pESCLEU used as cloning vector for dual expression, where VopX and VopE
variants cloned under GAL10 and GAL1 promoters, respectively.
Jiang et al., 2012). Like many other mitochondria targeted
effectors, localization of VopE is also dependent on the predicted
mitochondrial-targeting sequence spanning 23 amino acids at
the N-terminus. Deletion of MTS composed of 23 amino acids
(VopE1MTS) or substitution of leucine with glutamate at position
4 in the MTS (VopEL4E) abolishes the localization of VopE
in mitochondria. Unlike many mitochondria targeted effectors,
VopE does not promote the death of host cells. Functionally,
it modulates innate immune signaling through mitochondrial
dynamics (Suzuki et al., 2014).
Effectors having localization signals of various cellular
compartments (e.g., Map, ExoS, YopE etc.) still maintain toxicity
even after removal of the signal (Zhang and Barbieri, 2005;
Papatheodorou et al., 2006; Isaksson et al., 2009; Geissler et al.,
2010). Interestingly, one mitochondrial targeted effector of
enteropathogenic E. coli known as Map is found to be more toxic
after removal of MTS in yeast model system (Papatheodorou
et al., 2006). Keeping this in mind, we wanted to investigate
and garner additional insight on the functionality of VopE by
exploiting yeast model system. Our data clearly indicated that
ectopic expression of VopE and VopE1MTS caused toxicity to
yeast cells.
VopE is a member of bacterial GAP family protein. Structural
and functional analysis of certain bacterial GAPs clearly
establishes a communication network between several conserved
residues imparting the GAP function. By employing in silico
analysis followed by site-directed mutagenesis and functional
evaluation in yeast model system, we have identified several
residues other than R125 contributing to the lethal function of
VopE. It should be noted that natural sensitivity of BY4741 to
VopEmediated toxicity further aid in the identification of critical
residues in VopE.
There is now a large body of evidence on strategies used
by pathogens to control host signaling pathways especially
kinase signaling pathways (Krachler et al., 2011). Various kinase
signaling pathways such as nuclear factor-kB (NF-kB), mitogen-
activated protein kinase (MAPK), phosphatidylinositol 3-kinase
(PI3K), and p21-activated kinase (PAK) are hijacked by different
phylogenitically related and unrelated pathogens (Krachler et al.,
2011). Interestingly, T3SS effectors of some of these pathogens
(e.g., YopJ, VopA, OspF) have been shown to inhibit MAPK
kinase signaling pathways in yeast model system as well (Yoon
et al., 2003; Trosky et al., 2004; Kramer et al., 2007). With
the help of stressors, β-galactosidase assay and yeast deletion
strains, we have revealed that VopE and its variant VopE1MTS
modulate CWI-MAPK pathway in yeast model system, but the
mechanism is not clear. Yeast two-hybrid analysis of VopE1MTS
against prenylation defective GTPases (Rho1, Rho1Q68H, Rho2,
Rho2Q65H, CDC42, CDC42Q61L) failed to detect any possible
interaction (data not shown).
Being the principal signaling pathway maintaining the
architecture of yeast cell wall, the structural and functional
aspects of CWI MAPK pathway have been studied in great
detail (Levin, 2005). There is now a growing list of diverse
effector proteins (e.g., OspF of Shigella; Icm/Dot effectors of
C. burnetti; VopX of V. cholerae; YopE of Y. pestis) perturbing
the function of CWI-MAPK pathway in yeast model system
(Kramer et al., 2007; Lifshitz et al., 2014; Seward et al., 2015). As
evidenced, T3SS effectors of different bacteria target and alter the
function of various components of CWI pathway. While OspF
inhibits the phosphorylation of Slt2, the terminal MAP Kinase
of CWI pathway (Kramer et al., 2007), VopX modulates Rlm1
function and Rlm1 mediated downstream genes expression by
interacting components at the top of MAPK cascade (Alam et al.,
2011; Seward et al., 2015). Interestingly, CBU0388, CBU0885,
and CBU1676, effectors of C. burnetti interact differentially
with the various MAP Kinases of CWI pathway. While yeast
deletion mutants (1bck1 and 1mpk1) of CWI pathway exhibit
hypersensitivity upon expression of CBU1676 and CBU0885,
the same mutants result complete suppression of CBU0388
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lethality (Lifshitz et al., 2014). Our observation of VopEmediated
functional modulation of CWI-MAPK pathway will extend the
growing list of bacterial effectors targeting this important cellular
pathway in yeast. Finally, our co-expression of two effectors
interfering CWI-MAPK, VopE1MTS and VopX, exhibited the
suppression of lethality of the latter in the yeast model.
As demonstrated previously, VopE targets Miro GTPase and
causes functional modulation of the innate immune system
(Suzuki et al., 2014). The Miro ortholog in the budding yeast
is Gem1p (Frederick et al., 2004). If VopE lethality in yeast
is linked to Gem1p, then VopE should not exert toxicity
either in BY47411gem1 or its toxicity should be mitigated
upon over expression of gene encoding Gem1p. Our data
clearly demonstrated that VopE maintained its lethal property
in BY47411gem1 as well as BY4741 harboring Gem1p over-
expression construct, thereby indicating lethality of VopE is
not mediated by Gem1p. Interestingly, substitution of critical
arginine finger residue at position 125 (R125) by alanine (R125A)
conferred non-functionality in VopE and VopE1MTS further
corroborated that GAP function is required for the lethality of
these proteins in yeast system. Currently, the targeted GTPase(s)
of VopE and its variant in yeast model system is not known. This
warrants further investigation.
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